Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: results of phase IIIb BALLET trial in Spain

1. Ciruelos, E.
2. Vidal, M.
3. Martínez de Dueñas, E.
4. Martínez-Jáñez, N.
5. Fernández, Y.
6. García-Sáenz, J.A.
7. Murillo, L.
8. Carabantes, F.
9. Beliera, A.
10. Fonseca, R.
11. Gavilá, J.